There are two Melbourne events contributing to the noise.
Firstly we have the Hair Expo this weekend where the Professional range for Salons gets launched.
Secondly we have the participation of Cellmid in a huge Chinese attended (800) symposium of health, beauty and well being specifically set up for the collaboration of Australian and Chinese companies.
Its anyones guess as to what the outcome of a proven, clinically validated, hair care product for restoration of hair loss through midkine based FGF5 inhibitors being presented to 800 ready and willing Chinese pharmacists and distributors on a junket to Oz may be.
My guess: some will give it a go.
Price at posting .028
Up from recent 00.017 low
DYOR
Of course this is all on top of a US launch for evolis products due this month possibly via QVC and other dribs and drabs from various royalties and an accelerating Japanese market.
Never mind they have spawned two subsidiaries to handle midkine as it develops and to gain from venture capital and grants as unlisted entities.